4.7 Article

Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2

Journal

JOURNAL OF TRANSLATIONAL MEDICINE
Volume 12, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12967-014-0308-9

Keywords

Liver myofibroblasts; Natural killer cell; Immune-mediated liver injury; Liver failure; Hepatitis B

Funding

  1. National Science and Technology Major Project [2012ZX100020, 2012ZX10002004, 2012ZX10002007]
  2. China Postdoctoral Science Foundation [2013 M542228]
  3. Sun Yat-Sen University Clinical Research 5010 Program [2007029]
  4. National Natural Science Foundation of China [81202319, 30971356]
  5. Natural Science Fund of Guangdong province [S2012010009084, S2012040008104]
  6. New Teacher Fund of the Ministry of Education [20120171120103]

Ask authors/readers for more resources

Background: Natural killer (NK) cells are abundant in the liver and constitute a major innate immune component that contributes to immune-mediated liver injury. However, few studies have investigated the phenotypes and functions of NK cells involved in hepatitis B related liver failure (LF), and the precise mechanism underlying NK cell regulation is not fully understood. Methods: We detected the percentage and function of peripheral NK cells both in hepatitis B related LF patients and healthy volunteers by flow cytometry and isolated the liver myofibroblasts (LMFs) from hepatitis B related LF livers. To determine the possible effects of LMFs on NK cells, mixed cell cultures were established in vitro. Results: We found a down-regulated percentage of peripheral NK cells in hepatitis B related LF patients, and their NK cells also displayed decreased activated natural cytotoxicity receptors (NCRs) and cytokine production. In a co-culture model, LMFs sharply attenuated IL-2-induced NK cell triggering receptors, cytotoxicity, and cytokine production. The inhibitory effect of LMFs on NK cells correlated with their ability to produce prostaglandin (PG) E2. Conclusion: These data suggest that LMFs may protect against immune-mediated liver injury in hepatitis B related LF patients by inhibiting NK cell function via PGE2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available